S. Lee

发表

Comparison of Biolimus A9–Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery Lesions: A Randomized Long Drug-Eluting Stent V Trial

Seung‐Jung Park, S. Yun, Young-Hak Kim, 2014, Circulation. Cardiovascular interventions.

A Multicenter, Randomized, Double-Blind, Active-Controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia.

Simon S. Woo, D. Cha, Byeong‐Keuk Kim, 2022, Clinical therapeutics.

Durable polymer versus biodegradable polymer drug-eluting stents in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: a post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial.

Hyo‐Soo Kim, Hyun-Jae Kang, Jeehoon Kang, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial

M. Jeong, B. Kim, Sang-Wook Kim, 2021, The Lancet.

Intravascular ultrasound findings that are predictive of no reflow after percutaneous coronary intervention for saphenous vein graft disease.

M. Jeong, N. Weissman, G. Mintz, 2012, The American journal of cardiology.

Predictors of Favorable Angiographic Outcomes After Drug-Coated Balloon Use for de novo Small Vessel Coronary Disease (DCB-ONLY)

Byung Ok Kim, Sang-Wook Kim, E. Shin, 2021, Angiology.

Comparison of Resolute Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With De Novo Long Coronary Artery Lesions: A Randomized LONG-DES IV Trial

Seung‐Jung Park, S. Yun, Young-Hak Kim, 2012, Circulation. Cardiovascular Interventions.

Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial.

J. Chae, Seung‐Jung Park, S. Yun, 2019, Circulation.

Angiographic Outcomes and Predictors of Recurrent Restenosis after Cutting Balloon Angioplasty for the Treatment of In-Stent Restenosis

M. Jeong, E. Shin, J. Oh, 2003 .

Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.

M. Jeong, T. Hong, J. Kang, 2015, Clinical therapeutics.

Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS Trial.

Hyo‐Soo Kim, Hyun-Jae Kang, Jung-Hee Lee, 2022, JAMA cardiology.

The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial

M. Jeong, Si‐Hyuck Kang, Hyo‐Soo Kim, 2012, Trials.

Optimal strategy for side branch treatment in patients with left main coronary bifurcation lesions.

M. Jeong, K. Seung, Hyo‐Soo Kim, 2020, Revista espanola de cardiologia.

Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial

Yong Hwan Park, J. Chae, J. Bae, 2020, Journal of the American Heart Association.

Consensus statement on coronary intervention during the coronavirus disease 19 pandemic: from the Korean Society of Interventional Cardiology

J. Suh, T. Park, Sang-Hyun Kim, 2020, The Korean journal of internal medicine.

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia

B. Hong, E. Cho, Han-Young Jin, 2023, Journal of clinical hypertension.

Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial

Y. Jang, Y. Ko, Seung-Jun Lee, 2023, EClinicalMedicine.

Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent　- 3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial.

Jeehoon Kang, J. Oh, Kyung-Woo Park, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Consensus Statement on Coronary Intervention during the Coronavirus Disease 2019 (COVID-19) Pandemic: from the Korean Society of Interventional Cardiology (KSIC)

J. Suh, T. Park, D. Yang, 2020, Korean circulation journal.

Comparison of Resolute Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With De Novo Long Coronary Artery Lesions: A Randomized LONG-DES IV Trial

Seung‐Jung Park, S. Yun, Young-Hak Kim, 2012, Circulation. Cardiovascular interventions.

Harmonizing Optimal Strategy for Treatment of coronary artery diseases – comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial

J. Bae, Hyo‐Soo Kim, Hyun-Jae Kang, 2015, Trials.